Publicaciones en colaboración con investigadoras/es de Hospital Universitario Marqués de Valdecilla (17)

2022

  1. Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial

    Thrombosis and haemostasis, Vol. 122, Núm. 10, pp. 1653-1661

  2. Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis

    European Journal of Internal Medicine, Vol. 105, pp. 30-37

2020

  1. A multicenter national survey of children with SARS-CoV-2 infection admitted to Spanish Pediatric Intensive Care Units

    Intensive Care Medicine

  2. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain

    Critical care (London, England), Vol. 24, Núm. 1, pp. 666

2019

  1. ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain

    Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1763-1770

2018

  1. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)

    Oncologist, Vol. 23, Núm. 4, pp. 422-432

2017

  1. Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)

    Annals of Hematology, Vol. 96, Núm. 8, pp. 1323-1330

2016

  1. Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

    Nature Communications, Vol. 7

2011

  1. Long-term prognostic significance of response in multiple myeloma after stem cell transplantation

    Blood, Vol. 118, Núm. 3, pp. 529-534

  2. Risk-adapted treatment in clinical stage I testicular seminoma: The third Spanish Germ Cell Cancer Group study

    Journal of Clinical Oncology, Vol. 29, Núm. 35, pp. 4677-4681

2010

  1. Adjuvant docetaxel for high-risk, node-negative breast cancer

    New England Journal of Medicine, Vol. 363, Núm. 23, pp. 2200-2210

2009

  1. Pocket guide to invasive mycoses in onco-hematologic patients

    Revista iberoamericana de micología : órgano de la Asociación Española de Especialistas en Micología, Vol. Suppl, pp. 3-199

2003

  1. Autologous stem cell transplantation for primary refractory Hodgkin's disease: Results and clinical variables affecting outcome

    Annals of Oncology, Vol. 14, Núm. 5, pp. 745-751

  2. High-dose therapy in diffuse large cell lymphoma: Results and prognostic factors in 452 patients from the GEL-TAMO Spanish cooperative group

    Annals of Oncology, Vol. 14, Núm. 1, pp. 140-151

2002

  1. Quality of life in patients with schizophrenia in five European countries: The EPSILON study

    Acta Psychiatrica Scandinavica, Vol. 105, Núm. 4, pp. 283-292

2001

  1. Depressive disorders in Europe: Prevalence figures from the ODIN study

    British Journal of Psychiatry, Vol. 179, Núm. OCT., pp. 308-316

1995

  1. Allogeneic BMT in a patient with CML and prior disseminated infection by mycobacterium avium complex

    Bone Marrow Transplantation, Vol. 16, Núm. 1, pp. 183-185